Popular Trials
Chemotherapy
MTL-CEBPA + Sorafenib for Liver Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is testing an experimental treatment (MTL-CEBPA) in combination with a standard of care treatment (sorafenib) in patients with advanced liver cancer (hepatocellular carcinoma) as a result of hepatitis B and/or C infection.
Anti-viral
Preemptive Mavyret Therapy for Hepatitis C in Organ Transplant Recipients
Recruiting3 awardsPhase 4
Scottsdale, Arizona
This trial is testing if using two medicines together can stop Hepatitis C from spreading to people who get an organ transplant from a donor with Hepatitis C. The goal is to protect the new organ recipient from getting infected by the virus.
Direct Acting Antiviral
Hepatitis C Kidneys Transplantation for Kidney Failure
Recruiting1 awardPhase 2
Miami, Florida
This trial will study whether it is safe to transplant kidneys from donors with hepatitis C into recipients who do not have the virus. One-year allograft function and one-year risk of CMV infection will be compared between THINKER-NEXT kidney transplant recipients and matched recipients who received hepatitis C uninfected kidney transplants. The mortality rate of kidney transplant candidates who enroll in THINKER-NEXT and consent to offers of kidneys from HCV-infected donors will be compared to matched wait-listed patients who do not consent to receive HCV-infected kidneys. Lastly, renal pathologic findings will be compared among HC
Popular Filters
Trials for HCV Patients
Rapid Screening for Hepatitis C & B
Recruiting3 awardsPhase 4
Toronto, Ontario
This trial aims to study the effectiveness of rapid screening methods in diagnosing viral hepatitis infections compared to traditional methods. The goal is to provide same-day results to improve diagnosis rates and help healthcare providers engage with
Cannabinoid
Medical Cannabis for Chronic Pain
Recruiting1 awardPhase 2
Boca Raton, Florida
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Hepatitis C Positive Liver Transplants for Liver Transplant Recipients
Recruiting3 awardsPhase 2
Pittsburgh, Pennsylvania
This trial is testing the safety and efficacy of transplanting livers from donors who are either positive or negative for the Hepatitis C virus. Treatment and prophylaxis will be administered to the recipients based on the donor's status.
Trials for Opioid Use Disorder Patients
Cannabinoid
Medical Cannabis for Chronic Pain
Recruiting1 awardPhase 2
Boca Raton, Florida
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
NIATx Coaching for HIV, Hepatitis C, and Opioid Use Disorder Management
Recruiting1 award1 criteria
Morgantown, West Virginia
This trial will evaluate an intervention to introduce screening, evaluation and treatment of HIV/hep C/opioid use disorder in WV primary care clinics to improve health outcomes.
Behavioural Intervention
Transitional Care Program for HIV, Hepatitis C, and Substance Use Disorders
Recruiting1 award5 criteria
Fond Du Lac, Wisconsin
This trial tests a program called CJC-TraC that helps people leaving prison get the medical care they need. It focuses on those with HIV, Hepatitis C, or substance misuse history. The program coordinates their medical care to ensure they continue treatment after release. New treatments have made it easier and faster to cure Hepatitis C.
Behavioral Intervention
Harm Reduction Kiosk for Substance Use-Related Health Risks
Recruiting1 award
Lexington, Kentucky
This trial will test a new harm reduction kiosk called KyOSK in rural Appalachia to help people who use drugs stay safer. The kiosk provides clean needles and other supplies to reduce the risk of HIV, hepatitis C, and overdoses. The study aims to determine if this new approach is more effective and cost-efficient.
Trials With No Placebo
Rapid Screening for Hepatitis C & B
Recruiting3 awardsPhase 4
Toronto, Ontario
This trial aims to study the effectiveness of rapid screening methods in diagnosing viral hepatitis infections compared to traditional methods. The goal is to provide same-day results to improve diagnosis rates and help healthcare providers engage with
Cannabinoid
Medical Cannabis for Chronic Pain
Recruiting1 awardPhase 2
Boca Raton, Florida
This trial will investigate if medical cannabis can effectively reduce pain and improve quality of life for patients with chronic conditions. The study will gather data through an online questionnaire about patients' use of cannabis and its effects. Medical cannabis interacts with the body's natural system to help manage pain and other symptoms. Medical cannabis has been increasingly studied and used as an alternative treatment for managing chronic pain, with numerous studies supporting its potential benefits.
Hepatitis C Positive Liver Transplants for Liver Transplant Recipients
Recruiting3 awardsPhase 2
Pittsburgh, Pennsylvania
This trial is testing the safety and efficacy of transplanting livers from donors who are either positive or negative for the Hepatitis C virus. Treatment and prophylaxis will be administered to the recipients based on the donor's status.
Antiviral
Sofosbuvir/Velpatasvir for Kidney Transplant Recipients
Recruiting1 awardPhase 2
Pittsburgh, Pennsylvania
This trial is testing the safety and efficacy of transplanting kidneys from donors who are either hepatitis C seropositive and non-viremic, or seropositive and viremic, to recipients who are seronegative. Treatment and prophylaxis will be administered using a transmission-triggered approach for the first scenario and a prophylaxis approach for the later scenario.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.